DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT - Wikidata - awgldk - TriplyDB

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT

http://www.wikidata.org/entity/Q37295359

about

Validity, significance, strengths, limitations, and evidentiary value of real-world clinical data for combination therapy in Alzheimer's disease: comparison of efficacy and effectiveness studies.Efficacy and Tolerability of a Combination Treatment of Memantine and Donepezil for Alzheimer's Disease: A Literature Review Evidence.Errors in self-reports of health services use: impact on alzheimer disease clinical trial designs.Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus.Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial.Donepezil combined with natural hirudin improves the clinical symptoms of patients with mild-to-moderate Alzheimer's disease: a 20-week open-label pilot study Curing and caring: the work of primary care physicians with dementia patients.Combination treatments in Alzheimer's disease: risks and benefits.Benefits and risks of add-on therapies for Alzheimer's disease.Determining the minimum clinically important differences for outcomes in the DOMINO trial.Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial).STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation.Discontinuing cholinesterase inhibitors: results of a survey of Canadian dementia experts

P2860

Q34156798-53868798-050F-4B73-9425-B92D7C5B1C2F Q34301111-5E2DDB17-8FB5-4CEF-91B9-70724AB0EE9E Q34543773-E7297A5C-64E2-4786-A35B-49D7DEAC9999 Q34753885-24015BE9-4541-4AB7-82B6-8355F2D27DE0 Q34977377-5F42EF5A-3DF0-404F-95BD-7A69A5CA006A Q35966108-DAD43B24-5E3D-4569-9554-FFFB3EE84B07 Q36636371-BD717B5C-B0E1-4409-AB01-23A95BD66848 Q37737293-B9024A40-828F-4445-87F6-6FCDF614B5F4 Q38620338-1B8D469C-3808-478B-B4EC-626EBDAB66A7 Q42675662-BB82A0B2-530D-4313-B6B2-0441BD1E3782 Q47163824-D2848415-8B35-4387-8439-56598F5C2146 Q53550622-7E033F8A-88DC-4795-B593-71EB18035991 Q57271936-7F43310E-7F23-45B9-98E5-5383F968573E

P2860

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT

http://www.wikidata.org/entity/Q37295359

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

DOMINO-AD protocol: donepezil ...... 's disease - a multicentre RCT

@en

DOMINO-AD protocol: donepezil ...... s disease - a multicentre RCT.

@nl

type

label

DOMINO-AD protocol: donepezil ...... 's disease - a multicentre RCT

@en

DOMINO-AD protocol: donepezil ...... s disease - a multicentre RCT.

@nl

prefLabel

DOMINO-AD protocol: donepezil ...... 's disease - a multicentre RCT

@en

DOMINO-AD protocol: donepezil ...... s disease - a multicentre RCT.

@nl

P1433

Q37295359-A95EA03D-AA78-4D9D-ACA3-4927481D428E

P1476

Q37295359-322FAFAE-DF34-4A6A-BCF9-A3CFAB3DBBF1

P2093

Q37295359-08DB9978-EBCB-4BA0-9844-3D11AC8EC55B

Q37295359-08EDB9DD-E257-41CD-968F-54C6FC2B2F9C

Q37295359-178CBF60-3BA9-4363-A073-F115C4A955F8

Q37295359-31666BBB-D66C-44A7-A424-7A0C7AC06FD0

Q37295359-34AF74BF-900A-465E-A093-0C8D5DBE747D

Q37295359-614729BE-A8C4-4B39-97F0-2B2D13109435

Q37295359-655010ED-B672-47CE-BF15-B7602268B6FE

Q37295359-6C6F6995-1D9F-4401-91D1-32990CA976FA

Q37295359-77020C7A-97F5-4DF2-9FC9-70DFDC406C5F

Q37295359-80598AA1-D7E6-41CD-BEE9-09EBA01E4788

P2860

Q37295359-034D9F69-D6BA-4DCA-A45D-F768C3A7F58B

Q37295359-06567F28-28EE-422A-AFFD-2C2A14922630

Q37295359-06856545-E195-46B7-8F3A-04F8D1A93733

Q37295359-0D7E8FDE-58A4-4F1A-8C22-DAED8E3E301D

Q37295359-15889E19-7A42-49C9-AE2B-4A4EB3BF22ED

Q37295359-18216A69-B6A1-4297-B2DC-7B4FE7E20618

Q37295359-22DD8119-5CBE-417B-8310-14EC9F4F3854

Q37295359-2E72094F-A8CC-45EA-B6C7-D260440D4CBC

Q37295359-3ABD5284-ECD2-4ADB-80E5-BC6D9F5C5B8B

Q37295359-418A194C-0F2E-4F51-B716-1A6880FF7FFA

P2888

Q37295359-81E2D7C8-60EB-4F95-8ACF-A4383F6CD019

P304

Q37295359-C9AF6946-529D-4D42-B28B-10B73A65E3A8

P31

Q37295359-559901D4-DA3E-4192-B4C2-C0D4F3C96C5F

P356

Q37295359-94572B68-1E6F-4A2C-B2C8-6735F0402A33

P478

Q37295359-FF54F35E-A5CB-42BA-A5F0-55917351B9B6

P50

Q37295359-19E50C14-7C2C-4EB8-B1CF-AF63F9F4D310

Q37295359-3A21CC5F-83BE-4E8E-9BF5-5F0BD23C86AE

Q37295359-4AEF7120-0362-42EC-91AB-A40BA040440A

Q37295359-7B8805F5-AFA6-456D-8F4E-D03932A22860

Q37295359-86FBE36D-64FE-4319-81E3-9A60629FF342

Q37295359-A5A27FFD-5615-4902-9E1E-CA8CEF1E1100

Q37295359-ABB005E7-B60F-4631-A55E-29E2FB12EDE2

Q37295359-CEC8AE32-111A-4B34-90BF-0A5AA00861B2

Q37295359-D2B22C35-2B32-4591-9BAE-CDE918DCC4E6

Q37295359-D5DDF16E-2D6E-471B-B3CB-2D3BB69CF5B8

P577

Q37295359-E6AF0D82-9523-4702-A612-579EF61C56F7

P5875

Q37295359-07843471-67D0-4BB8-94C9-45DF1D30A838

P698

Q37295359-05A46481-A5CD-4120-A2A4-49220458BF8C

P921

Q37295359-494C95A7-D3DD-4C04-9261-29547CD9593B

Q37295359-6F61B7CA-E337-4486-94F6-105CB411242D

P932

Q37295359-74F4CF52-94D4-4256-BDF3-43FB4E6BCB11

P356

1745-6215-10-57

P1433

P1476

DOMINO-AD protocol: donepezil ...... 's disease - a multicentre RCT

@en

P2093

Ajay Macharouthu

http://www.w3.org/2001/XMLSchema#string

Alan Hughes

http://www.w3.org/2001/XMLSchema#string

Ashley Baldwin

http://www.w3.org/2001/XMLSchema#string

Bart Sheehan

http://www.w3.org/2001/XMLSchema#string

Bob Barber

http://www.w3.org/2001/XMLSchema#string

Caroline Onions

http://www.w3.org/2001/XMLSchema#string

Craig Ritchie

http://www.w3.org/2001/XMLSchema#string

DOMINO-AD team

http://www.w3.org/2001/XMLSchema#string

David Findlay

http://www.w3.org/2001/XMLSchema#string

Ed Juszczak

http://www.w3.org/2001/XMLSchema#string

P2860

Memantine for dementia

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial

EuroQol--a new facility for the measurement of health-related quality of life

Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients.

The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease.

P2888

1745-6215-10-57

P304

57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1745-6215-10-57

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Patrick Phillips

Richard G Brown

P577

2009-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26694154

http://www.w3.org/2001/XMLSchema#string

P698

19630974

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

multicenter trial

P932

2723100

http://www.w3.org/2001/XMLSchema#string